Retinoic acid syndrome: Recognition, prevention and management

Drug Safety

Volumn 18, Issue 4, 1998, Pages 273-279

  Fenaux, Pierre ^a   De Botton, Stéphane ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOKINE; DEXAMETHASONE; RETINOIC ACID;

ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; BLAST CELL; CYTOKINE RELEASE; EFFUSION; HEART FAILURE; HUMAN; KIDNEY FAILURE; LEUKOCYTE COUNT; MORTALITY; PRIORITY JOURNAL; RESPIRATORY DISTRESS; RETINOIC ACID SYNDROME; WEIGHT GAIN;

ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; CLINICAL TRIALS; CYTOKINES; DEXAMETHASONE; HEART FAILURE, CONGESTIVE; HUMANS; INFANT, NEWBORN; KIDNEY FAILURE; LEUKEMIA, PROMYELOCYTIC, ACUTE; LEUKOCYTE COUNT; RESPIRATORY DISTRESS SYNDROME, NEWBORN; SYNDROME; TRETINOIN; WEIGHT GAIN;

EID: 0031976484     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-199818040-00003     Document Type: Article

References (33)

1. Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the acute leukemias. Br J Haematol 1976; 33: 451-61
2. Bennet JM, Catovsky D, Daniel MT, et al. A variant form of hypergranular promyelocytic leukemia (M3). Ann Intern Med 1980; 92: 280-90
3. Larson RA, Kondo K, Vardiman JW, et al. Evidence for a 15; 17 translocalion in every patient with acute promyelocytic leukemia. Am J Med 1984; 76: 827-34
4. De The H, Lavau C, Marchio A, et al. The PML-RAR alpha fusion mRNA generated by the t(15; 17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 1991; 66: 675-87
5. Kakizuka A, Miller WH, Umesono K, et al. Chromosomal translocation t(15; 17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell 1991; 66: 663-74
6. Tallman MS, Kwaan HC. Reassessing the hemostatic disorder associated with acute promyelocytic leukemia. Blood 1992; 79: 543-51
7. Dombret H, Sutton L, Duarte M, et al. Combined therapy with all-trans retinoic acid and high-dose chemotherapy in patients with hypercytic acute promyelocytic leukemia and severe visceral hemorrhage. Leukemia 1992; 6: 1237-45
8. Kantarjian H, Keating M, Walters R. Acute promyelocytic leukemia: MD Anderson Hospital Experience. Am J Med 1986; 80: 789-97
9. Cunningham I, Gee T, Reich L. Acute promyelocytic leukemia: treatment results during a decade at Memorial Hospital. Blood 1989; 73: 1116-22
10. Fenaux P, Pollet JP, Vandenbossche L, et al. Treatment of acute promyelocytic leukemia: a report on 70 cases. Leuk Lymphoma 1991; 4: 249-56
11. Fenaux P, Tertian G, Castaigne S. A randomized trial of amacrine and rubidazone in 39 patients with acute promyelocytic leukemia. J Clin Oncol 1991; 9: 1556-61
12. Huang M, Yu-Chen Y, Shu-Rong C, et al. Use of all trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988; 72: 567-76
13. Chomienne C, Ballerini P, Balitrand N, et al. All trans retinoic acid in promyelocytic leukemias: II: in vitro studies structure function relationship. Blood 1990; 76: 1710-20
14. Castaigne S, Chomienne C, Daniel MT, et al. All trans retinoic acid as a differentiating therapy for acute promyelocytic leukemias: I: clinical results. Blood 1990; 76: 1704-9
15. Fenaux P, Le Deley MC, Castaigne S, et al. Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia: results of a multicenter randomized trial. Blood 1993; 82: 3241-9
16. Fenaux P, Wattel E, Archimbaud E, et al. Prolonged follow up confirms that all transretinoic acid (ATRA) followed by chemotherapy reduces the risk of relapse in newly diagnosed acute promyelocytic leukemia (APL). Blood 1994; 84: 666-7
17. Fenaux P, Chastang C, Chomienne C, et al. Tretinoin with chemotherapy in newly diagnosed acute promyelocytic leukaemia. Lancet 1994; 343: 1033-4
18. Kanamaru A, Takemoto Y, Tanimoto M, et al. All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia. Blood 1995; 85: 1202-6
19. Frankel SR, Eardley A, Heller G, et al. All-trans retinoic acid for acute promyelocytic leukemia: results of the New York study. Ann Int Med 1994; 120: 279-86
20. Degos L, Chomienne C, Daniel MT, et al. Treatment of first relapse in acute promyelocytic leukaemia with all trans retinoic acid. Lancet 1990; 2: 1440-1
21. Fenaux P, Castaigne S, Chomienne C, et al. All trans retinoic acid treatment for patients with acute promyelocytic leukemia. Leukemia 1992; 6: 64-72
22. Frankel SR, Eardley A, Lauwers G, et al. The 'retinoic acid syndrome' in acute promyelocytic leukemia. Ann Intern Med 1992; 117: 292-301
23. Fenaux P, Chastang C, Sanx M, et al. ATRA followed hy chemotherapy versus ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed APL: first interim results of APL93 trial [abstract]. Blood 1997; 90 Suppl. 1: 122a
24. Vahdat L, Maslak P, Miller WH, et al. Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of cytosis, low-dose chemotherapy. PML/RAR- alpha isoform, and CD13 expression in patients treated with all-trans retinoic acid. Blood 1994; 84: 3843-9
25. Wiley JS, Firkin FC. Reduction of pulmonary toxicity by prednisolone prophylaxis during all-trans retinoic acid treatment of acute promyelocytic leukemia. Leukemia 1995; 9: 774-8
26. Avvisati G, Lo Coco F, Diverio D, et al. Aida (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: a gruppo italiano malattie ematologiche maligne dello adulto (Gimema) pilot study. Blood 1996; 88: 1390-8
27. Tallman M, Andersen J, Schiffer C, et al. All transretinoic acid in acute promyelocytic leukemia. N Engl J Med 1997; 337: 345
28. Cortes JE, Kantarjian H, O'Brien S, et al. All-trans retinoic acid followed by chemotherapy for salvage of refractory or relapsed acute promyelocytic leukemia. Cancer 1994; 73: 2946-52
29. Stadler M, Ganser A, Hoelzer D. Acute promyelocytic leukemia. N Engl J Med 1994; 330: 140-1
30. De Gentile A, Toubert ME, Dubois C, et al. Induction of high-affinity GM-CSF receptors during all trans retinoic acid treatment of acute promyelocytic leukemia. Leukemia 1994; 8: 1758-62
31. Dubois C, Schlageter MH, De Gentle A, et al. Modulation of II-6 and II-1b and G-CSF secretion by all trans retinoic acid in acute promyelocytic leukemia. Leukemia 1994; 8: 1750-7
32. Dubois C, Schlageter MH, De Gentle A, et al. Hematopoietic growth factor expression and ATRA sensitivity in acute promyelocytic leukemia. Blood 1994; 83: 3264-70
33. Greiger S, Dombret H, Merle Beral H, et al. Study of microrheological properties of acute promyelocytic leukemia cells during all-trans retinoic acid therapy [abstract]. Br J Haematol 1994; 87 Suppl. 1: 57